Atos and Thales have announced the creation of Athea, a joint-venture that will develop a sovereign Big Data and Artificial Intelligence platform for public and private sector players in the defence, intelligence and internal state security communities. Athea will draw on the experience gained by both companies from the demonstration phase of the ARTEMIS programme, the Big Data platform of the French Ministry of Armed Forces. The contract to optimise and prepare the full-scale roll-out of the ARTEMIS platform was also awarded jointly to the two leaders by the French Defence Procurement Agency on April 30, 2021. The new joint venture will initially serve the French market before addressing European requirements at a later date. With the exponential rise in the number of sources of information and increased pressure to respond more quickly to potential issues, state agencies need to manage ever-greater volumes of heterogeneous data and accelerate the development of new AI applications where security and sovereignty are key.

The promise of big data and artificial intelligence is everywhere. One almost gets the impression that there is no problem that cannot be solved with these new technologies. The answer to everything is'big data and artificial intelligence'. This article was originally published in Smart Energy International 4-2019. Read the full digimag here or subscribe to receive a print copy here.

The promise of big data and artificial intelligence is everywhere. And, in all cases, so are the results. One almost gets the impression that there is no problem that cannot be solved with these new technologies. The answer to everything is'big data and artificial intelligence'. Open a web browser and you see advertising tuned to your latest online shopping.

HENDERSON, Nev.--(BUSINESS WIRE)--Quertle LLC has developed the first artificial intelligence and visual analytics big data (BioAI) platform for biomedical drug discovery. This platform combines machine learning, neural networks, and other AI methods to improve discovery and insight. The BioAI platform includes predictive visual analytics that accelerate search and discovery from the literature, enable discovery of documents that are otherwise overlooked and improve drug discovery. The AI-powered visualizations summarize an entire set of documents, detect trends and uncover hidden connections. Biomedical literature is the foundation of the 5 trillion health care market, serving as the basis for drug discovery, medical device opportunities, marketing decisions and direct health care.